Papers
5
Total Citations
17
H-Index
3
About
Wei-Ming Li is a leading urological surgeon and researcher whose work bridges precision surgical technique and evidence-based oncology, with a particular focus on upper tract urothelial carcinoma (UTUC) and prostate cancer. His research is especially impactful in Taiwan, a high-endemic region for UTUC, where his collaborative nationwide studies have provided critical treatment outcome analyses that challenge and refine global guidelines. Li’s most-cited work, a 2024 paper on hand-eye parameter estimation and line-structured light scanning calibration within a unified framework, demonstrates his innovative approach to surgical robotics and calibration—a technical contribution that has already garnered 6 citations. He has also led pivotal studies on segmental ureterectomy outcomes for UTUC, showing its viability in endemic populations, and on adjuvant therapy’s effectiveness for biochemical recurrence in prostate cancer patients with positive surgical margins. His cumulative sum analysis of the learning curve for laparoendoscopic single-site robot-assisted radical prostatectomy offers a practical roadmap for surgeons adopting this advanced technique. With over 17 citations across his top papers, Li’s work is shaping both surgical practice and oncological decision-making in urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5